Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma

[1]  G. Folkerts,et al.  Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide. , 1996, American journal of respiratory and critical care medicine.

[2]  R. Kacmarek,et al.  Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm. , 1996, American journal of respiratory and critical care medicine.

[3]  P. Barnes,et al.  Nitric oxide and asthmatic inflammation. , 1995, Immunology today.

[4]  I. Pavord,et al.  Bronchoprotective role for endogenous prostaglandin E2 , 1995, The Lancet.

[5]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[6]  J. Nadel,et al.  Evidence for reduction of bradykinin‐induced bronchoconstriction in guinea‐pigs by release of nitric oxide , 1994, British journal of pharmacology.

[7]  J. Calixto,et al.  Nitric oxide pathway‐mediated relaxant effect of bradykinin in the guinea‐pig isolated trachea , 1994, British journal of pharmacology.

[8]  G. Hedenstierna,et al.  Inhalation of nitric oxide modulates adult human bronchial tone. , 1993, The American review of respiratory disease.

[9]  J. Stamler,et al.  Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. , 1993, American journal of respiratory cell and molecular biology.

[10]  G. Folkerts,et al.  Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Role of the epithelium. , 1993, The American review of respiratory disease.

[11]  P. Jorens,et al.  L-arginine-dependent nitric oxide synthase: a new metabolic pathway in the lung and airways. , 1993, The European respiratory journal.

[12]  B. Mayer,et al.  Nitric oxide synthase in guinea pig lower airway innervation , 1993, Neuroscience Letters.

[13]  T. Takishima,et al.  Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist , 1992, The Lancet.

[14]  P. Barnes,et al.  Bradykinin and asthma. , 1992, Thorax.

[15]  D. Proud,et al.  Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. , 1992, The American review of respiratory disease.

[16]  M. Yacoub,et al.  Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. , 1992, European journal of pharmacology.

[17]  R. Djukanović,et al.  Mucosal inflammation in asthma. , 1990, The American review of respiratory disease.

[18]  P. Barnes,et al.  New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. , 1989, The Journal of allergy and clinical immunology.

[19]  Buist As.  Standardization of spirometry. , 1987 .

[20]  P. Barnes,et al.  Bradykinin-induced bronchoconstriction in humans. Mode of action. , 1987, The American review of respiratory disease.

[21]  F. Hargreave,et al.  Bronchial reactivity to inhaled histamine: a method and clinical survey , 1977, Clinical allergy.